EP Wealth Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.16M | Sell |
30,876
-167
| -0.5% | -$11.7K | 0.01% | 402 |
|
|
2025
Q1 | $2.28M | Buy |
31,043
+2,805
| +10% | +$206K | 0.02% | 346 |
|
|
2024
Q4 | $1.85M | Buy |
28,238
+7,802
| +38% | +$511K | 0.02% | 371 |
|
|
2024
Q3 | $1.59M | Buy |
20,436
+3,384
| +20% | +$264K | 0.01% | 402 |
|
|
2024
Q2 | $1.33M | Buy |
17,052
+732
| +4% | +$57.1K | 0.01% | 338 |
|
|
2024
Q1 | $1.11M | Sell |
16,320
-1,161
| -7% | -$78.7K | 0.01% | 361 |
|
|
2023
Q4 | $1.18M | Buy |
17,481
+1,837
| +12% | +$124K | 0.02% | 344 |
|
|
2023
Q3 | $1.06M | Buy |
15,644
+750
| +5% | +$50.8K | 0.02% | 320 |
|
|
2023
Q2 | $1.07M | Sell |
14,894
-3,321
| -18% | -$238K | 0.02% | 320 |
|
|
2023
Q1 | $3M | Buy |
18,215
+924
| +5% | +$152K | 0.05% | 191 |
|
|
2022
Q4 | $1.17M | Buy |
+17,291
| New | +$1.17M | 0.02% | 261 |
|
|
2022
Q3 | – | Sell |
-11,716
| Closed | -$774K | – | 359 |
|
|
2022
Q2 | $774K | Buy |
11,716
+3,483
| +42% | +$230K | 0.02% | 294 |
|
|
2022
Q1 | $546K | Sell |
8,233
-255
| -3% | -$16.9K | 0.01% | 363 |
|
|
2021
Q4 | $494K | Sell |
8,488
-511
| -6% | -$29.7K | 0.01% | 355 |
|
|
2021
Q3 | $540K | Buy |
8,999
+1,978
| +28% | +$119K | 0.01% | 317 |
|
|
2021
Q2 | $421K | Buy |
7,021
+772
| +12% | +$46.3K | 0.01% | 369 |
|
|
2021
Q1 | $311K | Buy |
6,249
+17
| +0.3% | +$846 | 0.01% | 401 |
|
|
2020
Q4 | $312K | Buy |
+6,232
| New | +$312K | 0.01% | 338 |
|
|
2020
Q2 | – | Sell |
-4,626
| Closed | -$207K | – | 369 |
|
|
2020
Q1 | $207K | Sell |
4,626
-798
| -15% | -$35.7K | 0.01% | 345 |
|
|
2019
Q4 | $270K | Sell |
5,424
-1,229
| -18% | -$61.2K | 0.01% | 348 |
|
|
2019
Q3 | $297K | Buy |
+6,653
| New | +$297K | 0.01% | 282 |
|